Special Survey Long-Term Treatment With Tiotropiume on COPD

This study is ongoing, but not recruiting participants.

Sponsored by:	Boehringer Ingelheim Pharmaceuticals
Information provided by:	Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier:	NCT00638183

Purpose

Since Spiriva Inhalation Capsules 18¿g (hereinafter ¿this product¿) are indicated for treatment of patients with chronic obstructive pulmonary disease (i.e. patients with chronic bronchitis or pulmonary emphysema) and usually intended for long-term use, the present survey is conducted to collect safety and effectiveness information on the use of this product for long time of period in daily clinical settings, and to obtain proper drug use information .

Condition
Pulmonary Disease, Chronic Obstructive

MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)

U.S. FDA Resources

Study Type:	Observational
Official Title:	Special Survey Long-Term Treatment

Further study details as provided by Boehringer Ingelheim Pharmaceuticals:

Estimated Enrollment:	300
Study Start Date:	April 2005
Estimated Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	20 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

COPD patient

Exclusion Criteria:

Patients with glaucoma
Patients with micturition disorder due to prostatic hyperplasia etc.
Patients with a history of hypersensitivity to atropine or its derivatives or to any component of this product

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00638183

Show 89 Study Locations

Sponsors and Collaborators

Boehringer Ingelheim Pharmaceuticals

Investigators

Study Chair:

Boehringer Ingelheim

Boehringer Ingelheim Pharmaceuticals

More Information

Responsible Party:	Boehringer Ingelheim ( Boehringer Ingelheim, Study Chair )
Study ID Numbers:	205.315
Study First Received:	March 11, 2008
Last Updated:	December 17, 2008
ClinicalTrials.gov Identifier:	NCT00638183
Health Authority:	Japan: Ministry of Health, Labor and Welfare

Study placed in the following topic categories:

Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Chronic Disease
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:

Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on January 16, 2009